English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNew study shows a non-invasive, painless laser can reduce risk of vision loss from dry AMD.
Tag: Macular Degeneration
New Public Service Announcement Shines a Spotlight on Expert Retina Specialist Care
The American Society of Retina Specialists (ASRS) has released new national television and radio public service announcements (PSAs) to highlight the critical role of retina specialists in preventing blindness in millions of Americans who experience retinal detachment, age-related macular degeneration (AMD), diabetic retinopathy, and other retinal conditions.
A new target for treatment of one type of macular degeneration
A new study in mice hints at the promise of an eventual alternative treatment option for the “wet” version of age-related macular degeneration (AMD).
The American Macular Degeneration Foundation Showcases Breakthrough AMD Research at ARVO 2024
The American Macular Degeneration Foundation supports a diverse portfolio of research investigations to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD.
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
A new approach to gene therapy resets cell homeostasis. Clinical trials to treat the retinal disorders Retinitis Pigmentosa, Stargardt’s, and Geographic Atrophy (late dry macular degeneration) are underway and showing promise.
Early Intervention is Critical to Saving Sight with Macular Degeneration
AMDF and TLI launch a campaign to raise awareness about macular degeneration with the official release of a short film featuring TLI fellow Laura Carabello.
The American Macular Degeneration Foundation Premieres Several New Short Films and Offers Free Resources During Age-related Macular Degeneration (AMD) and Low Vision Awareness Month
A 2024 AMD Awareness Month Resource Page, designed for the public and journalists, offers educational content, shareable talking points, fact sheets, shareable social media graphics, videos, opportunities for action, and more.
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2024 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Patricia Ann D’Amore, PhD, MBA, has been selected as the 2024 RPB David F. Weeks Award for Outstanding Vision Research (Weeks Award). Dr. D’Amore will receive her award and deliver a presentation during the AUPO 2024 Annual Meeting in Austin, Texas in February.
Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health
The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.
The American Macular Degeneration Foundation Premieres New Films During AMD Awareness Month 2023
The American Macular Degeneration Foundation will be hosting
multiple, awareness-spreading activities throughout February, which is AMD Awareness Month, including new films on living well with AMD.
Mount Sinai Researchers First to Identify That Two Separate Eye Diseases May Contribute to Common Blinding Eye Condition
Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.
The American Macular Degeneration Foundation Drives Research and Hope With New Grants
The foundation is investing $1.1 million in studies that hold the potential to set new standards in the prevention and treatment of age-related macular degeneration
A Cooking Series for People With Vision Loss
Science-based recipes for reducing the risk of macular degeneration progression (the AMD Diet), along with safe, low vision cooking practices
High-tech imaging reveals details about rare eye disorder
Using a new imaging technique, researchers from the National Eye Institute have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation. Addressing these differences may be key in designing effective treatments for this and other rare diseases. NEI is part of the National Institutes of Health.
Measuring Levels of Proteins in Eye Fluid May Accurately Predict Need for Lifelong Macular Degeneration Therapy
In a study of eye fluid from 38 patients, Johns Hopkins Medicine researchers say they have found that levels of a specific protein appears to help accurately predict whether people with the wet form of age-related macular degeneration may need lifelong, frequent eye injections to preserve vision or if they can be safely weaned off the treatments.
Young Investigator Leadership Awards Announced by The American Macular Degeneration Foundation
Awards will cover essential costs for young macular degeneration investigators.
New Procedure Improves Vision In Those With Macular Degeneration
A new corneal laser procedure for vision improvement in patients with late-stage, dry or wet age-related macular degeneration and other retinal disorders allows patients to regain several lines of useful vision, to read again, and to experience improved quality of life
Johns Hopkins Medicine Receives $16 Million Gift
Donation to support clinical scientists with precision medicine and vision researchPhilip Van Horn Gerdine. Credit: Pierce Harman Photography
Scientists Take Important Step Toward Using Retinal Cell Transplants to Treat Blindness
Retinal cells derived from a cadaver human eye survived when transplanted into the eyes of primate models, an important advance in the development of cell therapy to treat blindness, according to a study published on January 14 in Stem Cell Reports.
Study suggests sugary diet endangers waste-eating protein crucial to cellular repair
A high-sugar diet creates a ‘double jeopardy’ impact for a protein crucial to cellular housekeeping, a new study suggests. The protein offsets cell damage from sugar, but too much sugar renders it ineffective. The results may offer insight for reducing age-related degenerative disease.
Research Teams Creates Device Bringing Precision Medicine to Field of Ophthalmology
Innovative device ensures doctors obtain adequate fluid samples from the eye, helping with diagnosis and individualized treatment plans for patients.
HIV drugs could prevent diabetes, study suggests
Patients taking drugs called NRTIs to treat HIV and hepatitis B had a 33% lower risk of developing diabetes.
Nanoparticles enhance gene therapies for eye disease
NIBIB-funded researchers have created nanoparticles for successful gene therapy of a mouse model of macular degeneration. The nanoparticle carriers have the potential to significantly expand the effectiveness of gene therapies for human eye diseases, including blindness.
Scientists Use Nanoparticle-Delivered Gene Therapy to Inhibit Blinding Eye Disease in Rodents
Scientists use nanoparticle-delivered gene therapy to limit blinding retinal disease in rodents.
Exercise can slow or prevent vision loss, study finds
Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.
Artificial Intelligence Algorithm Can Rapidly Detect Severity of Common Blinding Eye Disease
A new artificial intelligence (AI) algorithm developed by researchers at New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD), a leading cause of vision loss in the United States.
New drug shows promise for treatment of cancer and other diseases
In the study, a group of lab mice that had consumed a diet that included the HM-10/10 peptide was found to have a significantly lower tumor load than mice that had not eaten the peptide.
Potential Way to Halt Blinding Macular Degeneration Identified
It would be the first treatment for “dry” age-related macular degeneration and could significantly improve treatment for wet AMD.
‘Ojos’ study to examine eye disease in Latino communities
With $9.7 million in funding from the National Eye Institute, researchers at the University of Illinois at Chicago will study the impact of chronic eye disease among Latinos.
Heating Techniques Could Improve Treatment of Macular Degeneration
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects. Jinglin Huang, a graduate student in medical engineering at Caltech, suggests inefficient fluid mixing of the injected medicine and the gel within the eye may be to blame.
Better Biosensor Technology Created for Stem Cells
A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders. The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors the fate of stem cells by detecting genetic material (RNA) involved in turning such cells into brain cells (neurons), according to a study in the journal Nano Letters.
Research to Prevent Blindness and Partners Award $1.2 Million In Grants for Novel AMD Research
Research to Prevent Blindness, the American Macular Degeneration Foundation and the International Retinal Research Foundation announce four new grantees for the Catalyst Awards for Innovative Research Approaches for AMD. New York, NY, June 24, 2019 — Research to Prevent Blindness,…
Cutting Edge Research Grants Announced by The American Macular Degeneration Foundation
Co-funded with Research to Prevent Blindness Northampton, MA – The American Macular Degeneration Foundation (AMDF), in partnership with Research to Prevent Blindness (RPB), has announced the recipients of the RPB/AMDF Catalyst Awards for Innovative Research Approaches for Age-Related Macular Degeneration,…